More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Over twenty risk loci have been identified for late onset Alzheimer’s disease (LOAD), most of which display relatively small effect sizes. Recently, a rare missense (R47H) variant, rs75932628 in TREM2, has been shown to mediate LOAD risk substantially in Icelandic and Caucasian populations. Here we present more evidence for the association of the R47H with LOAD risk in a Caucasian population comprising 4,567 LOAD cases and controls. Our results show that carriers of the R47H variant have a significantly increased risk for LOAD (OR=7.40, P=3.66E-06). In addition to AD risk, we also examined the association of R47H with AD-related phenotypes, including age-at-onset, psychosis, and amyloid deposition, but found no significant association. Our results corroborate those of other studies implicating TREM2 as a LOAD risk locus and indicate the need to determine its biological role in the context of neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 4×
“A GWAS of Alzheimer’s endophenotypes revealed associations with the TREM region on chromosome 6 and cerebrospinal fluid (CSF) tau and ptau levels, two biomarkers of LOAD.”
InfluentialVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 3×
“Discussion A rare TREM2 (R47H) variant that considerably increases LOAD risk has been identified in populations of European descent (Benitez et al., 2013, Giraldo et al., 2013, Guerreiro et al., 2013, Jonsson et al., 2013, Gonzalez et al., 2013).”
BackgroundInfluentialInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 2×
“…1,069 of whom were characterized during life for cognition and for psychotic symptoms by the Clinical Core of the ADRC, as previously used successfully to examine antemortem (DeMichele-Sweet et al., 2011 and Hollingworth et al., 2011) and post-mortem correlates of AD+P (Murray et al., 2012).”
BackgroundMethodNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 1×
“…ZCWPW1, CLU, PTK2B, PICALM, SORL1, CELF1, MS4A4/MS4A6E, SLC24A4/RIN3, FERMT2, CD33, ABCA7, and CASS4 —have been identified for LOAD in large genome-wide association studies (GWAS) (Harold et al., 2009, Hollingworth et al., 2011, Lambert et al., 2013, Naj et al., 2011, and Seshardi et al., 2010).”
BackgroundSelf-citationA mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · cited 1×
“Rare mutations affecting LOAD risk also have been identified with sequencing methods in the APP and PLD3 genes (Bamne et al., 2014, Cruchaga et al., 2014, Jonsson et al., 2012, and Kero et al., 2013).”
BackgroundGenome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798 · cited 1×
“However, Aβ1-42 clearance is significantly diminished in primary microglia from TREM2 knockout mice, and TREM2 causative mutations for other neurodegenerative diseases have been shown to alter general phagocytic ability, albeit to a greater degree than the R47H variant (Kleinberger et al., 2014).”
BackgroundPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · cited 2×
“early-onset neurodegeneration (Paloneva et al., 2002; Sorgana et al., 2003).”
BackgroundA role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475 · cited 2×
“although one study shows an increase of these unknown ligands on apoptotic cells, including neurons (Hsieh et al., 2009).”
BackgroundRare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., et al. (2014) · Nature · doi:10.1038/nature12825 · Cited by 461 · cited 2×
“Rare mutations affecting LOAD risk also have been identified with sequencing methods in the APP and PLD3 genes (Bamne et al., 2014, Cruchaga et al., 2014, Jonsson et al., 2012, and Kero et al., 2013).”
BackgroundSelf-citationRayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
Cruchaga, C., Kauwe, J. S. K., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.026 · Cited by 383
Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374 · cited 3×
“Discussion A rare TREM2 (R47H) variant that considerably increases LOAD risk has been identified in populations of European descent (Benitez et al., 2013, Giraldo et al., 2013, Guerreiro et al., 2013, Jonsson et al., 2013, Gonzalez et al., 2013).”
BackgroundInfluentialSchmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., Sutcliffe, J. G., & Carson, M. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01243.x · Cited by 351 · cited 1×
“Triggering receptor expressed on myeloid cells 2 (TREM2) is differentially expressed by microglia among different brain regions (Schmid et al., 2002).”
BackgroundCoding variants in TREM2 increase risk for Alzheimer's disease
Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314 · cited 1×
“…1036 3.03 (0.5-18.0) 0.39 Hooli et al, 2014, NIA-LOADb 1002 534 2.19 (1.04-4.51) 0.03 Slattery et al, 2014 2082 1648 2.63 (1.44-4.81) 0.000917 Jin et al, 2014 2190 2498 0.57 (0.05-6.30) 1.00 Miyashita et al, 2014 2037 9727 2.83 (1.45-4.50) 0.002 Jonsson et al, 2013 1091 1105 4.5 (1.7-11.90) …”
InfluentialInsights into TREM2 biology by network analysis of human brain gene expression data
Forabosco, P., Ramasamy, A., Trabzuni, D., Walker, R., Smith, C., Bras, J., Levine, A. P., Hardy, J., Pocock, J. M., Guerreiro, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.001 · Cited by 180 · cited 2×
“Furthermore, TREM2 has been shown to be a “hub” gene in the hippocampus, and its expression has been linked to the molecular signature of microglia, the cells responsible for clearing Ab in the brain (Forabosco et al., 2013).”
BackgroundTREM2 is associated with the risk of Alzheimer's disease in Spanish population
Benitez, B. A., Cooper, B., Pastor, P., Jin, S.-C., Lorenzo, E., Cervantes, S., & Cruchaga, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.018 · Cited by 163 · cited 4×
“Discussion A rare TREM2 (R47H) variant that considerably increases LOAD risk has been identified in populations of European descent (Benitez et al., 2013, Giraldo et al., 2013, Guerreiro et al., 2013, Jonsson et al., 2013, Gonzalez et al., 2013).”
BackgroundResultInfluentialGuerreiro, R., Bilgic, B., Guven, G., Brás, J., Rohrer, J., Lohmann, E., Hanagasi, H., Gurvit, H., & Emre, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.005 · Cited by 158 · cited 3×
“Discussion A rare TREM2 (R47H) variant that considerably increases LOAD risk has been identified in populations of European descent (Benitez et al., 2013, Giraldo et al., 2013, Guerreiro et al., 2013, Jonsson et al., 2013, Gonzalez et al., 2013).”
BackgroundInfluentialGiraldo, M., Lopera, F., Siniard, A. L., Corneveaux, J. J., Schrauwen, I., Carvajal, J., Muñoz, C., Ramirez-Restrepo, M., Gaiteri, C., Myers, A. J., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.016 · Cited by 147
Slattery, C. F., Beck, J. A., Harper, L., Adamson, G., Abdi, Z., Uphill, J., Campbell, T., Druyeh, R., Mahoney, C. J., Rohrer, J. D., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1751 · Cited by 119 · cited 3×
“Slattery et al (2014) also confirmed this association while reporting a smaller odds ratio (OR=2.19, 95% CI= 1.04-4.51), while Finelli et al. (2015) observed an odds ratio even higher than ours (OR=7.87, 95% CI=1.75-35.34).”
BackgroundInfluentialMa, J., Jiang, T., Tan, L., & Yu, J.-T. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8811-9 · Cited by 113
Roussos, P., Katsel, P., Fam, P., Tan, W., Purohit, D. P., & Haroutunian, V. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.013 · Cited by 103 · cited 3×
“…with LOAD Cases Controls Odds Ratio (95% CI) P Publication 474 608 7.87 (1.75-35.34) 0.007 Finelli et al, 2015 265 225 4.76 (1.37-16.54) 0.014 Roussos et al, 2014 3220 3112 1.67 (0.95-2.92) 0.034 Hooli et al, 2014a 917 199 4.97 (1.18-20.80) 0.004 Hooli et al, 2014, NIMHb 860 1036 3.03…”
ResultInfluentialAn Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene
Soragna, D. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.825-a · Cited by 75
Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
Kero, M., Paetau, A., Polvikoski, T., Tanskanen, M., Sulkava, R., Jansson, L., Myllykangas, L., & Tienari, P. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.017 · Cited by 72 · cited 1×
“Rare mutations affecting LOAD risk also have been identified with sequencing methods in the APP and PLD3 genes (Bamne et al., 2014, Cruchaga et al., 2014, Jonsson et al., 2012, and Kero et al., 2013).”
BackgroundYu, J.-T., Jiang, T., Wang, Y.-L., Wang, H.-F., Zhang, W., Hu, N., Tan, L., Sun, L., Tan, M.-S., Zhu, X.-C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.075 · Cited by 68
Cited by
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489
TREM2 in Neurodegenerative Diseases
Jay, T. R., von Saucken, V. E., & Landreth, G. E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0197-5 · Cited by 427
Molecular Basis of Familial and Sporadic Alzheimer's Disease
Dorszewska, J., Prendecki, M., Oczkowska, A., Dezor, M., & Kozubski, W. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150501 · Cited by 329
The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303
Metadata
- Authors
- Rosenthal, S. L., Bamne, M. N., Wang, X., Berman, S., Snitz, B. E., Klunk, W. E., Sweet, R. A., Demirci, F. Y., Lopez, O. L., & Kamboh, M. I.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 36
- Issue
- 8
- Pages
- 2443.e21-2443.e26
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2033068651
- Cited by
- 53
- References
- 26
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.